Oral infigratinib boosts growth velocity in achondroplasia study
1. Oral infigratinib achieved the highest growth velocity reported to date in a randomized achondroplasia trial, growing 2.10 cm/year faster ...
Tag: skeletal dysplasia
Clinical report outlines health supervision recommendations for patients with achondroplasia
1. In this report, the American Academy of Pediatrics (AAP) provides updated guidelines on diagnosis, genetic counseling, medical evaluation, and ...
